RNAGENE
Pipe
Pipeline
| Category | Indication | Product | Discovery | Pre-clinical |
Clinical Phase | ||
|---|---|---|---|---|---|---|---|
| Phase 1 | Phase 2 | Phase 3 | |||||
| Prophylactic Vaccine | SARS-CoV-2 | RGV-019 |  |
||||
| Influenza | RGV-105 |  |
|||||
| Zika virus | RGV-209 | |
|||||
| Cancer Immunotherapy | NSCLC | RGS-371 |  |
||||
| Multiple solid tumors | RGS-365 | |
|||||
| PRT | Rare Disease | RGD-404 | |
||||